MTOR and melanoma: However, USP22 inhibition could not further enhance the inhibitory effect on melanoma invasion in the presence of PI3K inhibitor (GDC‐0941), Akt inhibitor (MK‐2206), or mTOR inhibitor (CCI‐779) (Figure 4F,G).